Figure 3.
Dysregulated genes involved in thrombosis, HIF target genes, and inflammation in PV patients compared with controls by RNA-seq. Dysregulated thrombosis genes in PV granulocytes (A) and platelets (D). HIF-regulated genes in PV granulocytes (B) and platelets (E). Inflammatory genes in PV granulocytes (C) and platelets (F). Black dots represent genes that do not have significantly different expression levels compared with controls. Green dots are genes with log2 fold change >1 but not adjusted P (Adjp) < .05. Blue dots are genes with adjusted P < .05 but not log2 fold change >1. Genes labeled with red dots are differentially expressed genes with adjusted P < .05 and log2 fold change >1. F3, SELP, SERPINE1, VEGFA, and SLC2A1 were selected to validate expression levels by qRT-PCR (see Figure 5).

Dysregulated genes involved in thrombosis, HIF target genes, and inflammation in PV patients compared with controls by RNA-seq. Dysregulated thrombosis genes in PV granulocytes (A) and platelets (D). HIF-regulated genes in PV granulocytes (B) and platelets (E). Inflammatory genes in PV granulocytes (C) and platelets (F). Black dots represent genes that do not have significantly different expression levels compared with controls. Green dots are genes with log2 fold change >1 but not adjusted P (Adjp) < .05. Blue dots are genes with adjusted P < .05 but not log2 fold change >1. Genes labeled with red dots are differentially expressed genes with adjusted P < .05 and log2 fold change >1. F3, SELP, SERPINE1, VEGFA, and SLC2A1 were selected to validate expression levels by qRT-PCR (see Figure 5).

Close Modal

or Create an Account

Close Modal
Close Modal